Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion type Assertion NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_head.
- NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion description "[Here, we demonstrate that for one patient, with the first reported fibroblast growth factor receptor 2 (FGFR2) fusion transcript in ovarian cancer, circulating tumor DNA (ctDNA) is a more sensitive and specific biomarker than CA125, and it can also inform on a candidate therapeutic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_provenance.
- NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion evidence source_evidence_literature NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_provenance.
- NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion SIO_000772 24563622 NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_provenance.
- NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion wasDerivedFrom befree-20150227 NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_provenance.
- NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_assertion wasGeneratedBy ECO_0000203 NP542818.RAB0y-uumSSCODZ6qPo9-YCk7QmxoiQNDidomaNt8XTMY130_provenance.